Stephania cepharantha Hayata
Species
KNApSAcK Entry
| Organism name | Stephania cepharantha Hayata |
|---|---|
| Genus | Stephania |
| Family | Menispermaceae |
| Kingdom | Plantae |
NCBI taxonomy
Entry
| Linked NCBI taxonomy name | Stephania |
|---|---|
| Linked NCBI taxonomy ID | 147243 |
| Linked level | genus |
Family
| Family in NCBI taxonomy | Menispermaceae |
|---|---|
| ID | 3455 |
Kingdom (Superkingdom)
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
Plant class
| Plant class | eudicotyledons |
|---|---|
| ID | 71240 |
Metabolite list (50)
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
C00025310
|
Homoaromoline
/ (+)-Homoaromoline / (+)-Thalrugosamine |
CHEMBL507220
CHEMBL503522 CHEMBL509855 CHEMBL1185978 |
No. 10 | No. 4 |
|
|||
|
C00025745
|
3,4-Dehydrocycleanine
/ 3,4-Didehydrocycleanine / (+)-3,4-Dehydrocycleanine |
No. 10 | No. 4 |
|
||||
|
C00025789
|
Cepharanoline
|
CHEMBL496044
|
No. 10 | No. 4 |
|
|||
|
C00025746
|
3',4'-Dihydrostephasubine
|
No. 10 | No. 4 |
|
||||
|
C00025739
|
2-Norisotetrandrine
|
CHEMBL450175
|
No. 10 | No. 4 |
|
|||
|
C00025621
|
(-)-Norcycleanine
/ O7-Demethylcycleanine |
No. 10 | No. 4 |
|
||||
|
C00025260
|
2-Norberbamine
/ (+)-2-Norberbamine / 2-Demethylberbamine |
No. 10 | No. 4 |
|
||||
|
C00025981
|
Obamegine
/ Stepholine / (+)-Obamegine |
CHEMBL500609
CHEMBL452895 CHEMBL492604 CHEMBL1976284 |
C034784
|
No. 10 | No. 4 |
|
||
|
C00025276
|
Thalrugosine
/ (+)-Thalrugosine |
C060802
|
0 / 1 | No. 10 | No. 4 |
|
||
|
C00025604
|
Cycleanine
/ (-)-Cycleanine |
CHEMBL1711244
CHEMBL1983719 |
C037098
|
7 / 1 / 1 | No. 10 | No. 4 |
|
|
|
C00025313
|
Isotetrandrine
/ Isosinomenine A / O-Methylberbamine / O,O-Dimethylobamegine / O,O'-Dimethylobamegine / O,O-Dimethylstepholine / O,O'-Dimethylstepholine |
CHEMBL176045
CHEMBL367260 CHEMBL445477 CHEMBL449690 CHEMBL504958 CHEMBL504757 |
26 / 23 / 48 | No. 10 | No. 4 |
|
||
|
C00025827
|
Corydine
/ Glaucentrin / (+)-Corydine / Glaucentrine |
CHEMBL489524
CHEMBL2002847 |
C067341
|
1 / 0 / 0 | No. 20 | No. 4 |
|
|
|
C00025249
|
Stesakine
/ (-)-Stesakine |
No. 20 | No. 4 |
|
||||
|
C00025962
|
Norisoboldine
/ Laurelliptine / (+)-Norisoboldine / (+)-Laurelliptine / (+)-N-Norisoboldine / (S)-(+)-Laurelliptine |
CHEMBL375902
|
No. 20 | No. 4 |
|
|||
|
C00025235
|
Crebanin
/ (-)-Crebanine |
CHEMBL604339
CHEMBL1989287 |
C061009
|
1 / 0 / 0 | No. 20 | No. 4 |
|
|
|
C00025991
|
O-Nornuciferine
/ (-)-Nornuciferine / (-)-N-Methylasimilobine |
CHEMBL2316499
|
No. 20 | No. 4 |
|
|||
|
C00025932
|
Litseferine
/ Litseglutine A / (+)-Litseferine |
No. 20 | No. 4 |
|
||||
|
C00025675
|
Lauroscholtzine
/ 2-O-Methylboldine / N-Methyllaurotetanine / (+)-N-Methyllaurotetanine |
CHEMBL464099
|
1 / 1 / 0 | No. 20 | No. 4 |
|
||
|
C00025905
|
Isocorytuberine
/ (+)-Isocorytuberine / O10-Demethylcorydine |
No. 20 | No. 4 |
|
||||
|
C00025630
|
Stephanine
/ l-Stephanine / (-)-Stephanine / (R)-(-)-Stephanine |
CHEMBL601020
|
C054160
|
1 / 0 / 0 | No. 20 | No. 4 |
|
|
|
C00026092
|
Scoulerine
/ (-)-Scoulerine |
CHEMBL191133
CHEMBL1235966 CHEMBL1395394 |
27 / 19 / 15 | No. 37 | No. 4 |
|
||
|
C00025935
|
Lysicamine
/ Oxonuciferine |
CHEMBL510090
|
C069090
|
No. 74 |
|
|||
|
C00025790
|
Cepharanone A
|
CHEMBL603073
|
1 / 0 / 0 | No. 125 |
|
|||
|
C00025787
|
Cepharadione A
|
CHEMBL235921
|
No. 125 |
|
||||
|
C00025791
|
Cepharanone B
/ Aristolactam BII / Aristololactam B II |
CHEMBL226772
|
C064674
|
No. 125 |
|
|||
|
C00025652
|
d-Coclaurine
/ Sanjoinine K / (R)-Coclaurine / (+)-Coclaurine / (+)-R-Coclaurine |
CHEMBL256448
CHEMBL453291 CHEMBL446211 |
8 / 17 / 10 | No. 253 | No. 4 |
|
||
|
C00025924
|
Juziphine
/ Yuziphine / (+)-Juziphine |
CHEMBL462956
|
No. 253 | No. 4 |
|
|||
|
C00025666
|
(S)-Laudanine
/ (+)-Laudanidine / L-(+)-Laudanidine |
CHEMBL251625
CHEMBL1425007 |
2 / 0 / 0 | No. 345 | No. 4 |
|
||
|
C00026017
|
Protosinomenine
/ (S)-Protosinomenine |
No. 345 | No. 4 |
|
||||
|
C00025687
|
Stephodeline
/ (+)-Stephodeline |
No. 346 | No. 4 |
|
||||
|
C00025784
|
Cephamonine
/ (-)-Cephamonine / (-)-8-Methoxysinomenine |
No. 346 | No. 4 |
|
||||
|
C00025718
|
14-Episinomenine
|
CHEMBL248095
CHEMBL1551847 CHEMBL1555036 CHEMBL1589951 CHEMBL1591798 |
9 / 8 / 8 | No. 346 | No. 4 |
|
||
|
C00025688
|
Tannagine
/ (+)-Tannagine / 14-Epi-(+)-stephodeline |
No. 346 | No. 4 |
|
||||
|
C00025794
|
Cephatonine
/ (-)-Cephatonine |
No. 346 | No. 4 |
|
||||
|
C00025786
|
Cephamuline
/ (-)-Cephamuline |
No. 346 | No. 4 |
|
||||
|
C00025792
|
Cephasamine
|
No. 346 | No. 4 |
|
||||
|
C00025846
|
Dehydrostephanine
/ 1,2-Methylenedioxy-8-methoxydehydroaporphine |
C030171
|
No. 416 |
|
||||
|
C00026125
|
Dehydrocrebanine
|
No. 416 |
|
|||||
|
C00025629
|
Sinoacutine
/ (-)-Sinoacutine / (-)-Salutaridine |
CHEMBL402782
CHEMBL404097 |
3 / 4 / 2 | No. 426 | No. 4 |
|
||
|
C00025102
|
Aknadinine
/ 4-Demethylhasubanonine / O4-Demethylhasubanonine |
CHEMBL1098359
|
C099121
|
3 / 0 / 0 | No. 559 | No. 4 |
|
|
|
C00025101
|
Aknadilactam
|
CHEMBL1097185
|
3 / 0 / 0 | No. 559 | No. 4 |
|
||
|
C00025104
|
Cepharamine
|
No. 559 | No. 4 |
|
||||
|
C00025272
|
Stepharine
/ (+)-Stepharine |
CHEMBL463957
CHEMBL1975436 |
C009320
|
No. 688 |
|
|||
|
C00001862
|
Glaziovine
/ L-Glaziovine / N-Methylcrotsparine / L-(-)-N-Methylcrotsparine |
CHEMBL1980854
|
C007847
|
No. 688 |
|
|||
|
C00025788
|
Cepharadione B
|
CHEMBL396085
|
C457230
|
No. 800 |
|
|||
|
C00025785
|
Cephamorphinanine
/ (-)-Cephamorphinanine |
No. 3033 |
|
|||||
|
C00025793
|
Cephasugine
/ (-)-Cephasugine |
No. 3033 |
|
|||||
|
C00026047
|
Stephaoxocanine
/ (+)-Stephaoxocanine |
No. 3650 |
|
|||||
|
C00025783
|
Cephakicine
|
No. 3886 |
|
|||||
|
C00026046
|
Stephaoxocanidine
|
No. 4747 |
|
Human Protein / Gene in interactions
52 ChEMBL Protein in interactions
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P24941 | Cyclin-dependent kinase 2 | Cdc2 | C00025235 C00025629 C00025630 C00025718 C00025790 C00025827 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00025313 C00025604 C00025652 C00025666 C00026092 | 0 / 0 |
| Q99700 | Ataxin-2 | Unclassified protein | C00025313 C00025604 C00026092 | 1 / 1 |
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00025313 C00025718 C00026092 | 1 / 0 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00025313 C00025718 C00026092 | 0 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00025652 C00025718 C00026092 | 0 / 0 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00025101 C00025102 C00025629 | 0 / 0 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00025313 C00025604 C00026092 | 0 / 0 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00025313 C00025718 C00026092 | 0 / 1 |
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00025313 C00025604 C00026092 | 0 / 0 |
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00025313 C00025604 | 0 / 0 |
| O75164 | Lysine-specific demethylase 4A | Enzyme | C00025313 C00025604 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00025652 C00025718 | 4 / 3 |
| P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | C00025675 C00026092 | 1 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00025652 C00026092 | 0 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00025313 C00026092 | 0 / 1 |
| O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00025313 C00026092 | 1 / 0 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00025101 C00025102 | 0 / 0 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00025313 C00026092 | 0 / 0 |
| P39748 | Flap endonuclease 1 | Enzyme | C00025313 C00026092 | 0 / 0 |
| Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00025313 C00026092 | 0 / 0 |
| Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00025718 C00026092 | 0 / 0 |
| Q8IUX4 | DNA dC->dU-editing enzyme APOBEC-3F | Enzyme | C00025604 C00026092 | 0 / 0 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00025101 C00025102 | 0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00025313 C00026092 | 1 / 1 |
| O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00025652 C00025666 | 0 / 0 |
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00025652 | 7 / 3 |
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00025313 | 2 / 0 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00025718 | 0 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00026092 | 0 / 0 |
| P00734 | Prothrombin | S1A | C00025629 | 4 / 2 |
| P06280 | Alpha-galactosidase A | Enzyme | C00025313 | 1 / 1 |
| O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00025313 | 0 / 0 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00026092 | 2 / 0 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00026092 | 0 / 0 |
| P08183 | Multidrug resistance protein 1 | drug | C00025313 | 1 / 0 |
| P02545 | Prelamin-A/C | Unclassified protein | C00026092 | 11 / 10 |
| O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00025313 | 0 / 0 |
| P29466 | Caspase-1 | C14 | C00026092 | 0 / 0 |
| P04062 | Glucosylceramidase | Enzyme | C00025652 | 6 / 4 |
| P01375 | Tumor necrosis factor | Secreted protein | C00025718 | 3 / 4 |
| O14727 | Apoptotic protease-activating factor 1 | Unclassified protein | C00026092 | 0 / 0 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00026092 | 0 / 0 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00026092 | 0 / 0 |
| P14618 | Pyruvate kinase PKM | Enzyme | C00025652 | 0 / 0 |
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00025313 | 0 / 0 |
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00025313 | 1 / 1 |
| Q16637 | Survival motor neuron protein | Unclassified protein | C00025313 | 4 / 1 |
| P04637 | Cellular tumor antigen p53 | Transcription Factor | C00025313 | 7 / 37 |
| O00255 | Menin | Unclassified protein | C00025313 | 2 / 5 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00025313 | 1 / 2 |
| Q9Y253 | DNA polymerase eta | Enzyme | C00026092 | 1 / 1 |
Related Diseases
Diseases related to proteins in ChEMBL interactions
OMIM (62)
| OMIM | preferred title | UniProt |
|---|---|---|
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
| #202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
| #103780 | Alcohol dependence |
P14416
|
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #114500 | Colorectal cancer; crc |
P84022
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #133239 | Esophageal cancer |
P04637
|
| #301500 | Fabry disease |
P06280
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #608013 | Gaucher disease, perinatal lethal |
P04062
|
| #230800 | Gaucher disease, type i |
P04062
|
| #230900 | Gaucher disease, type ii |
P04062
|
| #231000 | Gaucher disease, type iii |
P04062
|
| #231005 | Gaucher disease, type iiic |
P04062
|
| #137800 | Glioma susceptibility 1; glm1 |
O75874
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #610424 | Hepatitis b virus, susceptibility to |
P01375
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
| #151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
| #211980 | Lung cancer |
P04637
|
| #611162 | Malaria, susceptibility to |
P01375
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #174800 | Mccune-albright syndrome; mas |
P63092
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #159900 | Myoclonic dystonia |
P14416
|
| #166350 | Osseous heteroplasia, progressive; poh |
P63092
|
| #260500 | Papilloma of choroid plexus; cpp |
P04637
|
| #168600 | Parkinson disease, late-onset; pd |
P04062
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
| #172700 | Pick disease of brain |
P10636
|
| #102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
| #614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
| #613679 | Prothrombin deficiency, congenital |
P00734
|
| #103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
| #603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
| #612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
| #607507 | Psoriatic arthritis, susceptibility to |
P01375
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
| #253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
| #253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
| #271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
| #275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
| #601367 | Stroke, ischemic |
P00734
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
| #278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG DISEASE (75)
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00223 | Inherited thrombophilia |
P00734
(related)
|
| H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
| H00079 | Asthma |
P01375
(related)
|
| H00080 | Systemic lupus erythematosus |
P01375
(related)
P01375 (marker) |
| H00083 | Allograft rejection |
P01375
(related)
|
| H00084 | Graft-versus-host disease |
P01375
(related)
P01375 (marker) |
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
| H00126 | Gaucher disease |
P04062
(related)
|
| H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
| H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
| H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
| H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
| H00006 | Hairy-cell leukemia |
P04637
(related)
|
| H00008 | Burkitt lymphoma |
P04637
(related)
|
| H00009 | Adult T-cell leukemia |
P04637
(related)
|
| H00010 | Multiple myeloma |
P04637
(related)
|
| H00013 | Small cell lung cancer |
P04637
(related)
|
| H00014 | Non-small cell lung cancer |
P04637
(related)
|
| H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
| H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
| H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
| H00018 | Gastric cancer |
P04637
(related)
|
| H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
| H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
| H00022 | Bladder cancer |
P04637
(related)
|
| H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
| H00026 | Endometrial Cancer |
P04637
(related)
|
| H00027 | Ovarian cancer |
P04637
(related)
|
| H00028 | Choriocarcinoma |
P04637
(related)
|
| H00029 | Vulvar cancer |
P04637
(related)
|
| H00031 | Breast cancer |
P04637
(related)
|
| H00032 | Thyroid cancer |
P04637
(related)
|
| H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
| H00038 | Malignant melanoma |
P04637
(related)
|
| H00039 | Basal cell carcinoma |
P04637
(related)
|
| H00040 | Squamous cell carcinoma |
P04637
(related)
|
| H00041 | Kaposi's sarcoma |
P04637
(related)
|
| H00042 | Glioma |
P04637
(related)
P04637 (marker) |
| H00044 | Cancer of the anal canal |
P04637
(related)
|
| H00046 | Cholangiocarcinoma |
P04637
(related)
|
| H00047 | Gallbladder cancer |
P04637
(related)
|
| H00048 | Hepatocellular carcinoma |
P04637
(related)
|
| H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
| H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
| H01007 | Choroid plexus papilloma |
P04637
(related)
|
| H00021 | Renal cell carcinoma |
P04637
(marker)
|
| H00125 | Fabry disease |
P06280
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
| H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
| H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
| H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|